TP53 and cancer: To assess whether the accumulated DNA damage perturbed cell cycle progression and leads to cancer cell death, which attribute to the diminished cell viability and reduced colony formation observed in TP53-deficient cells following gemcitabine-induced-DNA damage, we evaluated cell cycle at 48 and 72 h in H1299 TP53-Null and overexpressed TP53-WT cells.